144 related articles for article (PubMed ID: 35176893)
1. Geographic Variation in Otolaryngologist Intranasal Steroid Prescribing Patterns Among Medicare Beneficiaries.
Wu FM; Ulloa R; Badash I; Hur K
Ann Otol Rhinol Laryngol; 2023 Feb; 132(2):126-132. PubMed ID: 35176893
[TBL] [Abstract][Full Text] [Related]
2. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
Morse E; Fujiwara RJT; Mehra S
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
[TBL] [Abstract][Full Text] [Related]
3. Trends in Nasal Spray Prescribing Patterns by Otolaryngologists in the US Medicare Population.
Kim C; Tran E; Kim I; Hur K
Ann Otol Rhinol Laryngol; 2022 Nov; 131(11):1185-1193. PubMed ID: 34823366
[TBL] [Abstract][Full Text] [Related]
4. Telemedicine Services Provided to Medicare Beneficiaries by Otolaryngologists Between 2010 and 2018.
Miller LE; Rathi VK; Kozin ED; Naunheim MR; Xiao R; Gray ST
JAMA Otolaryngol Head Neck Surg; 2020 Sep; 146(9):816-821. PubMed ID: 32701120
[TBL] [Abstract][Full Text] [Related]
5. Opioid prescribing patterns among otolaryngologists: Crucial insights among the medicare population.
Svider PF; Arianpour K; Guo E; Folbe E; Zuliani G; Lin H; Eloy JA; Folbe AJ
Laryngoscope; 2018 Jul; 128(7):1576-1581. PubMed ID: 29446449
[TBL] [Abstract][Full Text] [Related]
6. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties.
Luetzenberg FS; Jiang N
Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137
[TBL] [Abstract][Full Text] [Related]
7. Do Patterns of Opioid Prescriptions to Medicare Beneficiaries Differ Between Oral and Maxillofacial Surgeons Practicing in Urban and Rural Settings?
Wang TT; Nadella S; Lee CC; Hersh EV; Tannyhill RJ; Panchal N
J Oral Maxillofac Surg; 2022 Apr; 80(4):614-619. PubMed ID: 34856159
[TBL] [Abstract][Full Text] [Related]
8. Opioid-limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries.
Kim YJ; Kim I; Badash I; West J; Hur K
Laryngoscope Investig Otolaryngol; 2023 Aug; 8(4):921-929. PubMed ID: 37621267
[TBL] [Abstract][Full Text] [Related]
9. Predictors of regional Medicare expenditures for otolaryngology physician services.
Smith A; Handorf E; Arjmand E; Lango MN
Laryngoscope; 2017 Jun; 127(6):1312-1317. PubMed ID: 27859299
[TBL] [Abstract][Full Text] [Related]
10. A Critical Analysis of Medicare Claims for Otolaryngology Procedures.
Youssef SJ; Vyas KS
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):929-938. PubMed ID: 31237824
[TBL] [Abstract][Full Text] [Related]
11. Five-Year Comparative Analysis of Medicare Opioid Prescription Volume Among Oral and Maxillofacial Surgeons.
Patel NA; Keith DA
J Oral Maxillofac Surg; 2019 Dec; 77(12):2439-2446. PubMed ID: 31404518
[TBL] [Abstract][Full Text] [Related]
12. A Work in Progress: National Opioid Prescription Reductions Across Orthopaedic Subspecialties in a Contemporary Medicare Sample of 5,026,911 Claims.
Acuña AJ; Jella TK; Samuel LT; Cwalina TB; Kim TS; Kamath AF
J Am Acad Orthop Surg Glob Res Rev; 2021 May; 5(5):. PubMed ID: 34014856
[TBL] [Abstract][Full Text] [Related]
13. Otolaryngologist Characteristics and Outlier Use of Balloon Sinuplasty in the Medicare Population.
Exilus SD; Haut ER; Canner J; Boss EF; Rowan NR
Laryngoscope; 2022 Jul; 132(7):1340-1345. PubMed ID: 34405899
[TBL] [Abstract][Full Text] [Related]
14. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States.
Erie JC; Barkmeier AJ; Hodge DO; Mahr MA
Ophthalmology; 2016 Jun; 123(6):1257-62. PubMed ID: 26976701
[TBL] [Abstract][Full Text] [Related]
15. Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: retrospective cohort analysis of pharmacy claims data.
Garris C; Shah M; D'Souza A; Stanford R
Clin Drug Investig; 2009; 29(8):515-26. PubMed ID: 19591513
[TBL] [Abstract][Full Text] [Related]
16. Supply of obstetrician-gynecologists and gynecologic oncologists to the US Medicare population: a state-by-state analysis.
Talbott J; Khurana A; Wasson M
Am J Obstet Gynecol; 2023 Feb; 228(2):203.e1-203.e9. PubMed ID: 36088988
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intranasal corticosteroids.
Szefler SJ
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
[TBL] [Abstract][Full Text] [Related]
18. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
[TBL] [Abstract][Full Text] [Related]
19. Opioid prescription by gynecologic oncologists: An analysis of Medicare Part D claims.
Samuel D; Nevadunsky NS; Miller DT; Isani S; Kuo DYS; Gressel GM
Curr Probl Cancer; 2021 Apr; 45(2):100655. PubMed ID: 32994074
[TBL] [Abstract][Full Text] [Related]
20. Clinician Use and Payments by Medical Specialty for Audiometric and Vestibular Testing Among US Medicare Beneficiaries.
Adams ME; Yueh B; Marmor S
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):143-149. PubMed ID: 31855260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
